Back to search

Article

Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: A retrospective and observational study

2023-03-30

Abstract excerpt

Medication-related osteonecrosis of the jaw (MRONJ) is a refractory osteonecrosis caused by antiresorptive agents such as bisphosphonate and denosumab (DMB). In MRONJ surgery, computed tomography (CT) is generally used to determine the extent of bone resection. However, in some recent MRONJ cases, no abnormal findings were detected on CT. Therefore, we aimed to clarify the characteristics of MRONJ without osteolys...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
71a9c234-af1f-523b-b57d-e268010f309a
DOI
10.21203/rs.3.rs-2667138/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Medication-related osteonecrosis of the jaw without osteolysis on computed tomography: A retrospective and observational studyDOI 10.21203/rs.3.rs-2667138/v1
Prevalence of late stage in 507 Medication-related osteonecrosis of the jaws (MRONJ) sites: comparison between cancer and osteometabolic patientsSemantic proximity
Denosumab-Related Osteonecrosis of the Jaw: a five year monocentric retrospective study of Ancona General HospitalSemantic proximity
A Clinical Study Of Segmental Mandibulectomy For Medication-Related Osteonecrosis Of The JawSemantic proximity
Etiological Study on Changes in Oral Microbial Microenvironment Induced by Anti-Osteoclastic Drugs and Subsequent Development of MRONJSemantic proximity
Staging of osteonecrosis of the jaw requires computed tomography for accurate definition of the extent of bony disease.Semantic proximity
Osteonecrosis of the Jaw in Patients with Clear Cell Renal Cell Carcinoma Treated with Targeted Agents: A Case Series and Large-Scale Pharmacovigilance AnalysisSemantic proximity
Simplifying the dental/periodontal management of patients with metabolic bone fragility receiving treatment with denosumabSemantic proximity
Osteonecrosis of the Jaw and the Role of MacrophagesSemantic proximity
Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?Semantic proximity
Surgical treatment of MRONJ in oncology and non-oncology patients: a retrospective studySemantic proximity
RANKL inhibition with denosumab improves fibrous dysplasia by decreasing lesional cell proliferation and increasing osteogenesisSemantic proximity
Ostenonecrosis of the jaw (ONJ) after denosumab in patients with giant cell tumor of bone (GCTB): a single institution analysis of a prospective, international study 20062004Semantic proximity
Select a neighboring publication to make it the new centre.